MedTrace Logo

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

NCT03761797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1164

Last updated 2023-01-23

Study results available
· View outcomes & findings →

Summary

Study objectives is to investigate the safety of long-term daily use of TRADIANCE® Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

TRADIANCE® Combination Tablets AP

Fixed dose combination

DRUG

TRADIANCE® Combination Tablets BP

Fixed dose combination

Sponsors & Collaborators

Principal Investigators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2021-03-10
Completion
2021-04-27
FDA Drug
Yes

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03761797 on ClinicalTrials.gov